Published in Biotech Business Week, March 31st, 2003
The 12-sipper Off-Chip Mobility Shift chip will significantly increase throughput, important in high-volume experimentation. The 4-sipper On-Chip Mobility Shift Assay will further simplify drug discovery screening assays for a number of target classes, including kinases.
"These are significant product line extensions for us and for our customers," said Michael Merion, Caliper's vice president of Marketing and Sales. "A number of important pharmaceutical firms rely on our microfluidics platform to provide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.